Hungarian bird flu vaccine to be tested on 500 volunteers
A vaccine developed in Hungary against the H5N1 bird flu virus will be tested on five hundred volunteers, over the next few weeks, the Hungarian public television said late on Friday. A recent test on 150 people verified that the vaccine has been effective in protecting humans from the H5N1 virus, Omninvest, the vaccine’s developer and owner, said. Additional testing in Hungary is to pave the way for the vaccine's official registration according to European Union rules, MTV said. Several countries in Asia and the Middle-East have signed up to buy in the vaccine for tens of billions of forints, the broadcast said, adding that it will cost about 30-35 euros per dose. Omninvest said in April that it had sufficient capacity to produce a volume enough to protect all Hungarians in case of a pandemic. (MTI)
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.